Skip to main content

Advertisement

Table 1 Table 1

From: Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial

  baseline At 3 months At 6 months At 12 months
CHAQ-pain subscale 0.886 0.466 0.386 0.338
CHAQ-disability subscale 0.76 0.491 0.425 0.343
CHAQ-severity subsccale 0.398 0.248 0.184 0.207
Number of swollen joints 2.4 0.8 0.6 0.4
Number of tender joints 2.6 1.4 1.1 0.8
Number of joints with LROM 3.3 2.8 2.4 2.4
Physician global (VAS) 2.4 1.0 0.8 0.6
Elevated CRP 45.7% 14.3% 12.5% 42.9%
Elevated Sedimentation rate 43.8% 17.5% 21.1% 42.1%